Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.

Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J, Paul Vonsattel J, Younkin SG, Bennett DA, De Jager PL, Larson EB, Crane PK, Keene CD, Kamboh MI, Kofler JK, Duque L, Gilbert JR, Gwirtsman HE, Buxbaum JD, Dickson DW, Frosch MP, Ghetti BF, Lunetta KL, Wang LS, Hyman BT, Kukull WA, Foroud T, Haines JL, Mayeux RP, Pericak-Vance MA, Schneider JA, Trojanowski JQ, Farrer LA, Schellenberg GD, Beecham GW, Montine TJ, Jun GR; Alzheimer’s Disease Genetics Consortium.

Nat Commun. 2020 Feb 3;11(1):667. doi: 10.1038/s41467-019-14279-8.

2.

Brain imaging measurements of fibrillar amyloid-β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele.

Ghisays V, Goradia DD, Protas H, Bauer RJ 3rd, Devadas V, Tariot PN, Lowe VJ, Knopman DS, Petersen RC, Jack CR Jr, Caselli RJ, Su Y, Chen K, Reiman EM.

Alzheimers Dement. 2020 Jan 16. doi: 10.1016/j.jalz.2019.08.195. [Epub ahead of print]

PMID:
31831374
3.

Neuropsychological decline up to 20 years before incident mild cognitive impairment.

Caselli RJ, Langlais BT, Dueck AC, Chen Y, Su Y, Locke DEC, Woodruff BK, Reiman EM.

Alzheimers Dement. 2019 Nov 28. pii: S1552-5260(19)35485-8. doi: 10.1016/j.jalz.2019.09.085. [Epub ahead of print]

PMID:
31787561
4.

Impact of Zumba on Cognition and Quality of Life is Independent of APOE4 Carrier Status in Cognitively Unimpaired Older Women: A 6-Month Randomized Controlled Pilot Study.

Stonnington CM, Krell-Roesch J, Locke DEC, Hentz JG, Dueck AC, Geda YE, Tariot PN, Caselli RJ.

Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317519868370. doi: 10.1177/1533317519868370. Epub 2019 Aug 11.

PMID:
31401841
5.

Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease.

Malek-Ahmadi M, Beach TG, Zamrini E, Adler CH, Sabbagh MN, Shill HA, Jacobson SA, Belden CM, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Caviness JN, Driver-Dunckley E, Mehta SH, Shprecher DR, Spann BM, Tariot P, Davis KJ, Long KE, Nicholson LR, Intorcia A, Glass MJ, Walker JE, Callan M, Curry J, Cutler B, Oliver J, Arce R, Walker DG, Lue LF, Serrano GE, Sue LI, Chen K, Reiman EM.

PLoS One. 2019 Jun 25;14(6):e0217566. doi: 10.1371/journal.pone.0217566. eCollection 2019.

6.

Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age.

Wingo AP, Dammer EB, Breen MS, Logsdon BA, Duong DM, Troncosco JC, Thambisetty M, Beach TG, Serrano GE, Reiman EM, Caselli RJ, Lah JJ, Seyfried NT, Levey AI, Wingo TS.

Nat Commun. 2019 Apr 8;10(1):1619. doi: 10.1038/s41467-019-09613-z.

7.

Applying surface-based hippocampal morphometry to study APOE-E4 allele dose effects in cognitively unimpaired subjects.

Dong Q, Zhang W, Wu J, Li B, Schron EH, McMahon T, Shi J, Gutman BA, Chen K, Baxter LC, Thompson PM, Reiman EM, Caselli RJ, Wang Y.

Neuroimage Clin. 2019;22:101744. doi: 10.1016/j.nicl.2019.101744. Epub 2019 Mar 4.

8.

Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.

Pottier C, Ren Y, Perkerson RB 3rd, Baker M, Jenkins GD, van Blitterswijk M, DeJesus-Hernandez M, van Rooij JGJ, Murray ME, Christopher E, McDonnell SK, Fogarty Z, Batzler A, Tian S, Vicente CT, Matchett B, Karydas AM, Hsiung GR, Seelaar H, Mol MO, Finger EC, Graff C, Öijerstedt L, Neumann M, Heutink P, Synofzik M, Wilke C, Prudlo J, Rizzu P, Simon-Sanchez J, Edbauer D, Roeber S, Diehl-Schmid J, Evers BM, King A, Mesulam MM, Weintraub S, Geula C, Bieniek KF, Petrucelli L, Ahern GL, Reiman EM, Woodruff BK, Caselli RJ, Huey ED, Farlow MR, Grafman J, Mead S, Grinberg LT, Spina S, Grossman M, Irwin DJ, Lee EB, Suh E, Snowden J, Mann D, Ertekin-Taner N, Uitti RJ, Wszolek ZK, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Hodges JR, Piguet O, Geier EG, Yokoyama JS, Rissman RA, Rogaeva E, Keith J, Zinman L, Tartaglia MC, Cairns NJ, Cruchaga C, Ghetti B, Kofler J, Lopez OL, Beach TG, Arzberger T, Herms J, Honig LS, Vonsattel JP, Halliday GM, Kwok JB, White CL 3rd, Gearing M, Glass J, Rollinson S, Pickering-Brown S, Rohrer JD, Trojanowski JQ, Van Deerlin V, Bigio EH, Troakes C, Al-Sarraj S, Asmann Y, Miller BL, Graff-Radford NR, Boeve BF, Seeley WW, Mackenzie IRA, van Swieten JC, Dickson DW, Biernacka JM, Rademakers R.

Acta Neuropathol. 2019 Jun;137(6):879-899. doi: 10.1007/s00401-019-01962-9. Epub 2019 Feb 9.

PMID:
30739198
9.

A concise and persistent feature to study brain resting-state network dynamics: Findings from the Alzheimer's Disease Neuroimaging Initiative.

Kuang L, Han X, Chen K, Caselli RJ, Reiman EM, Wang Y; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2019 Mar;40(4):1062-1081. doi: 10.1002/hbm.24383. Epub 2018 Dec 19.

10.

Neuropsychological comparison of incident MCI and prevalent MCI.

Hansen A, Caselli RJ, Schlosser-Covell G, Golafshar MA, Dueck AC, Woodruff BK, Stonnington CM, Geda YE, Locke DEC.

Alzheimers Dement (Amst). 2018 Sep 27;10:599-603. doi: 10.1016/j.dadm.2018.08.009. eCollection 2018.

11.

Age stratification corrects bias in estimated hazard of APOE genotype for Alzheimer's disease.

Liu L, Caselli RJ.

Alzheimers Dement (N Y). 2018 Oct 30;4:602-608. doi: 10.1016/j.trci.2018.09.006. eCollection 2018.

12.

Isometry Invariant Shape Descriptors for Abnormality Detection on Brain Surfaces Affected by Alzheimer's Disease.

Tu Y, Wen C, Zhang W, Wu J, Zhang J, Chen K, Caselli RJ, Reiman EM, Reiman EM, Wang Y.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:427-4631. doi: 10.1109/EMBC.2018.8513129.

13.

Brain-Derived Neurotrophic Factor and Its Associations with Metabolism and Physical Activity in a Latino Sample.

Fonseca-Portilla R, Krell-Roesch J, Shaibi GQ, Caselli RJ, Mandarino LJ, Zhang N, Hentz JG, Coletta DK, de Filippis EA, Dawit S, Geda YE.

Metab Syndr Relat Disord. 2019 Mar;17(2):75-80. doi: 10.1089/met.2018.0028. Epub 2018 Nov 10.

14.

APOE ε2 is associated with increased tau pathology in primary tauopathy.

Zhao N, Liu CC, Van Ingelgom AJ, Linares C, Kurti A, Knight JA, Heckman MG, Diehl NN, Shinohara M, Martens YA, Attrebi ON, Petrucelli L, Fryer JD, Wszolek ZK, Graff-Radford NR, Caselli RJ, Sanchez-Contreras MY, Rademakers R, Murray ME, Koga S, Dickson DW, Ross OA, Bu G.

Nat Commun. 2018 Oct 22;9(1):4388. doi: 10.1038/s41467-018-06783-0.

15.

Reply to Comment on "Personality Changes During the Transition from Cognitive Health to Mild Cognitive Impairment".

Caselli RJ, Locke DEC, Woodruff BK, Langlais BT, Dueck AC.

J Am Geriatr Soc. 2019 Jan;67(1):192-193. doi: 10.1111/jgs.15622. Epub 2018 Oct 5. No abstract available.

PMID:
30289960
16.

At the Intersection of Patient Experience Data, Outcomes Research, and Practice: Analysis of HCAHPS Scores in Neurology Patients.

Hanson KT, Zalewski NL, Hocker SE, Caselli RJ, Habermann EB, Thiels CA.

Mayo Clin Proc Innov Qual Outcomes. 2018 May 24;2(2):137-147. doi: 10.1016/j.mayocpiqo.2018.03.007. eCollection 2018 Jun.

17.

Subjective Cognitive Impairment and the Broad Autism Phenotype.

Caselli RJ, Langlais BT, Dueck AC, Locke DEC, Woodruff BK.

Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):284-290. doi: 10.1097/WAD.0000000000000273.

18.

HIPPOCAMPUS MORPHOMETRY STUDY ON PATHOLOGY-CONFIRMED ALZHEIMER'S DISEASE PATIENTS WITH SURFACE MULTIVARIATE MORPHOMETRY STATISTICS.

Wu J, Zhang J, Shi J, Chen K, Caselli RJ, Reiman EM, Wang Y.

Proc IEEE Int Symp Biomed Imaging. 2018 Apr;2018:1555-1559. doi: 10.1109/ISBI.2018.8363870. Epub 2018 May 24.

19.

MULTI-TASK SPARSE SCREENING FOR PREDICTING FUTURE CLINICAL SCORES USING LONGITUDINAL CORTICAL THICKNESS MEASURES.

Zhang J, Tu Y, Li Q, Caselli RJ, Thompson PM, Ye J, Wang Y.

Proc IEEE Int Symp Biomed Imaging. 2018 Apr;2018:1406-1410. doi: 10.1109/ISBI.2018.8363835. Epub 2018 May 24.

20.

Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci.

Sanchez-Contreras MY, Kouri N, Cook CN, Serie DJ, Heckman MG, Finch NA, Caselli RJ, Uitti RJ, Wszolek ZK, Graff-Radford N, Petrucelli L, Wang LS, Schellenberg GD, Dickson DW, Rademakers R, Ross OA.

Mol Neurodegener. 2018 Jul 9;13(1):37. doi: 10.1186/s13024-018-0267-3.

21.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sánchez-Valle R, Antonell A, Lladó A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Öijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R.

Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.

22.

Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.

Stonnington CM, Chen Y, Savage CR, Lee W, Bauer RJ III, Sharieff S, Thiyyagura P, Alexander GE, Caselli RJ, Locke DEC, Reiman EM, Chen K.

J Alzheimers Dis. 2018;63(2):603-615. doi: 10.3233/JAD-170852.

23.

Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer's Disease.

Yin J, Han P, Song M, Nielsen M, Beach TG, Serrano GE, Liang WS, Caselli RJ, Shi J.

Mol Neurobiol. 2018 Nov;55(11):8592-8601. doi: 10.1007/s12035-018-0977-0. Epub 2018 Mar 24.

24.

Anticholinergic Medications and Cognitive Function in Late Midlife.

Limback-Stokin MM, Krell-Roesch J, Roesler K, Hansen A, Stonnington CM, Temkit M, Caselli RJ, Geda YE.

Alzheimer Dis Assoc Disord. 2018 Jul-Sep;32(3):262-264. doi: 10.1097/WAD.0000000000000251. No abstract available.

25.

Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions.

Burns CM, Kaszniak AW, Chen K, Lee W, Bandy DJ, Caselli RJ, Reiman EM.

J Alzheimers Dis. 2018;62(2):833-840. doi: 10.3233/JAD-170767.

26.

Personality Changes During the Transition from Cognitive Health to Mild Cognitive Impairment.

Caselli RJ, Langlais BT, Dueck AC, Henslin BR, Johnson TA, Woodruff BK, Hoffman-Snyder C, Locke DEC.

J Am Geriatr Soc. 2018 Apr;66(4):671-678. doi: 10.1111/jgs.15182. Epub 2018 Jan 17.

27.

Deep Learning based Classification of FDG-PET Data for Alzheimers Disease Categories.

Singh S, Srivastava A, Mi L, Caselli RJ, Chen K, Goradia D, Reiman EM, Wang Y.

Proc SPIE Int Soc Opt Eng. 2017 Oct;10572. pii: 105720J. doi: 10.1117/12.2294537. Epub 2017 Nov 17.

28.

Multi-Source Multi-Target Dictionary Learning for Prediction of Cognitive Decline.

Zhang J, Li Q, Caselli RJ, Thompson PM, Ye J, Wang Y.

Inf Process Med Imaging. 2017 Jun;10265:184-197. doi: 10.1007/978-3-319-59050-9_15. Epub 2017 May 23.

29.

TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics.

Mackenzie IR, Nicholson AM, Sarkar M, Messing J, Purice MD, Pottier C, Annu K, Baker M, Perkerson RB, Kurti A, Matchett BJ, Mittag T, Temirov J, Hsiung GR, Krieger C, Murray ME, Kato M, Fryer JD, Petrucelli L, Zinman L, Weintraub S, Mesulam M, Keith J, Zivkovic SA, Hirsch-Reinshagen V, Roos RP, Züchner S, Graff-Radford NR, Petersen RC, Caselli RJ, Wszolek ZK, Finger E, Lippa C, Lacomis D, Stewart H, Dickson DW, Kim HJ, Rogaeva E, Bigio E, Boylan KB, Taylor JP, Rademakers R.

Neuron. 2017 Aug 16;95(4):808-816.e9. doi: 10.1016/j.neuron.2017.07.025.

30.

Multivariate analyses of peripheral blood leukocyte transcripts distinguish Alzheimer's, Parkinson's, control, and those at risk for developing Alzheimer's.

Delvaux E, Mastroeni D, Nolz J, Chow N, Sabbagh M, Caselli RJ, Reiman EM, Marshall FJ, Coleman PD.

Neurobiol Aging. 2017 Oct;58:225-237. doi: 10.1016/j.neurobiolaging.2017.05.012. Epub 2017 Jun 20.

PMID:
28716532
31.

Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease.

Stonnington CM, Harel B, Locke DEC, Hentz JG, Zhang N, Maruff P, Caselli RJ.

Alzheimer Dis Assoc Disord. 2017 Oct-Dec;31(4):271-277. doi: 10.1097/WAD.0000000000000200.

32.

Alzheimer Disease: Scientific Breakthroughs and Translational Challenges.

Caselli RJ, Beach TG, Knopman DS, Graff-Radford NR.

Mayo Clin Proc. 2017 Jun;92(6):978-994. doi: 10.1016/j.mayocp.2017.02.011. Review.

33.

Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.

Williams SM, Schulz P, Rosenberry TL, Caselli RJ, Sierks MR.

J Alzheimers Dis. 2017;58(1):23-35. doi: 10.3233/JAD-161116.

PMID:
28372328
34.

A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor.

Han P, Serrano G, Beach TG, Caselli RJ, Yin J, Zhuang N, Shi J.

J Neuropathol Exp Neurol. 2017 Jan 1;76(1):44-51. doi: 10.1093/jnen/nlw105.

35.

Hyperbolic Space Sparse Coding with Its Application on Prediction of Alzheimer's Disease in Mild Cognitive Impairment.

Zhang J, Shi J, Stonnington C, Li Q, Gutman BA, Chen K, Reiman EM, Caselli RJ, Thompson PM, Ye J, Wang Y.

Med Image Comput Comput Assist Interv. 2016 Oct;9900:326-334. doi: 10.1007/978-3-319-46720-7_38. Epub 2016 Oct 2.

36.

Clinical Impact of Amyloid Positron Emission Tomography-Is It Worth the Cost?

Caselli RJ, Woodruff BK.

JAMA Neurol. 2016 Dec 1;73(12):1396-1398. doi: 10.1001/jamaneurol.2016.3792. No abstract available.

PMID:
27802483
37.

Conformal invariants for multiply connected surfaces: Application to landmark curve-based brain morphometry analysis.

Shi J, Zhang W, Tang M, Caselli RJ, Wang Y.

Med Image Anal. 2017 Jan;35:517-529. doi: 10.1016/j.media.2016.09.001. Epub 2016 Sep 6.

38.

MORPHOMETRIC ANALYSIS OF HIPPOCAMPUS AND LATERAL VENTRICLE REVEALS REGIONAL DIFFERENCE BETWEEN COGNITIVELY STABLE AND DECLINING PERSONS.

Zhang W, Shi J, Stonnington C, Bauer RJ 3rd, Gutman BA, Chen K, Thompson PM, Reiman EM, Caselli RJ, Wang Y.

Proc IEEE Int Symp Biomed Imaging. 2016 Apr;2016:14-18.

39.

Impact of Personality on Cognitive Aging: A Prospective Cohort Study.

Caselli RJ, Dueck AC, Locke DE, Henslin BR, Johnson TA, Woodruff BK, Hoffman-Snyder C, Geda YE.

J Int Neuropsychol Soc. 2016 Aug;22(7):765-76. doi: 10.1017/S1355617716000527. Epub 2016 Jun 27.

PMID:
27346168
40.

Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition.

Filon JR, Intorcia AJ, Sue LI, Vazquez Arreola E, Wilson J, Davis KJ, Sabbagh MN, Belden CM, Caselli RJ, Adler CH, Woodruff BK, Rapscak SZ, Ahern GL, Burke AD, Jacobson S, Shill HA, Driver-Dunckley E, Chen K, Reiman EM, Beach TG, Serrano GE.

J Neuropathol Exp Neurol. 2016 Aug;75(8):748-754. doi: 10.1093/jnen/nlw047. Epub 2016 Jun 12.

PMID:
27297671
41.

Sex and post-menopause hormone therapy effects on hippocampal volume and verbal memory.

Braden BB, Dassel KB, Bimonte-Nelson HA, O'Rourke HP, Connor DJ, Moorhous S, Sabbagh MN, Caselli RJ, Baxter LC.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2017 May;24(3):227-246. doi: 10.1080/13825585.2016.1182962. Epub 2016 Jun 4.

42.

Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study.

Li B, Shi J, Gutman BA, Baxter LC, Thompson PM, Caselli RJ, Wang Y; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2016 Apr 11;11(4):e0152901. doi: 10.1371/journal.pone.0152901. eCollection 2016.

43.

Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.

Monsell SE, Kukull WA, Roher AE, Maarouf CL, Serrano G, Beach TG, Caselli RJ, Montine TJ, Reiman EM.

JAMA Neurol. 2015 Oct;72(10):1124-31. doi: 10.1001/jamaneurol.2015.1721.

44.

Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.

Dugger BN, Davis K, Malek-Ahmadi M, Hentz JG, Sandhu S, Beach TG, Adler CH, Caselli RJ, Johnson TA, Serrano GE, Shill HA, Belden C, Driver-Dunckley E, Caviness JN, Sue LI, Jacobson S, Powell J, Sabbagh MN.

BMC Neurol. 2015 Aug 20;15:146. doi: 10.1186/s12883-015-0403-4.

45.

Midlife personality and risk of Alzheimer disease and distress: A 38-year follow-up.

Caselli RJ, Coon EA, Johansson L.

Neurology. 2015 Jul 21;85(3):298-9. doi: 10.1212/WNL.0000000000001777. No abstract available.

PMID:
26195239
46.

Predictive testing for Alzheimer's disease: suicidal ideation in healthy participants.

Caselli RJ, Marchant GE, Hunt KS, Henslin BR, Kosiorek HE, Langbaum J, Robert JS, Dueck AC.

Alzheimer Dis Assoc Disord. 2015 Jul-Sep;29(3):252-4. doi: 10.1097/WAD.0000000000000097. No abstract available.

47.

APOE ε4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons.

Krell-Roesch J, Woodruff BK, Acosta JI, Locke DE, Hentz JG, Stonnington CM, Stokin GB, Nagle C, Michel BF, Sambuchi N, Caselli RJ, Geda YE.

J Neuropsychiatry Clin Neurosci. 2015 Fall;27(4):322-5. doi: 10.1176/appi.neuropsych.14100268. Epub 2015 Mar 24.

48.

Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region.

Chen K, Roontiva A, Thiyyagura P, Lee W, Liu X, Ayutyanont N, Protas H, Luo JL, Bauer R, Reschke C, Bandy D, Koeppe RA, Fleisher AS, Caselli RJ, Landau S, Jagust WJ, Weiner MW, Reiman EM; Alzheimer’s Disease Neuroimaging Initiative.

J Nucl Med. 2015 Apr;56(4):560-6. doi: 10.2967/jnumed.114.149732. Epub 2015 Mar 5.

49.

A novel cortical thickness estimation method based on volumetric Laplace-Beltrami operator and heat kernel.

Wang G, Zhang X, Su Q, Shi J, Caselli RJ, Wang Y; Alzheimer’s Disease Neuroimaging Initiative.

Med Image Anal. 2015 May;22(1):1-20. doi: 10.1016/j.media.2015.01.005. Epub 2015 Feb 3.

50.

Physical activity level and future risk of mild cognitive impairment or dementia: a critically appraised topic.

Schlosser Covell GE, Hoffman-Snyder CR, Wellik KE, Woodruff BK, Geda YE, Caselli RJ, Demaerschalk BM, Wingerchuk DM.

Neurologist. 2015 Feb;19(3):89-91. doi: 10.1097/NRL.0000000000000013.

PMID:
25692517

Supplemental Content

Loading ...
Support Center